Labeler · US market

Aveva Drug Delivery Systems Inc.

Aveva Drug Delivery Systems Inc. is a US drug labeler with US FDA registrations covering 4 drug concepts (4 currently active) across 28 packages.

ACTIVE — US

openFDA · updated weekly

Labeler codes3215

Active drugs4

Registrations23 active / 23

Packages28

Sole supplier of0 drugs

Portfolio4 drugs · US

Every drug concept this labeler has US registrations for, by package count.

Drug	Type	NDCs	Packages	Status
Nicotine Transdermal System patch	otc	6	11	SUPPLYING
Fentanyl patch, extended release	rx	8	8	SUPPLYING
Buprenorphine patch, extended release	rx	5	5	SUPPLYING
Buprenorphine And Naloxone film	rx	4	4	SUPPLYING

At a glance

TypeLabeler
Labeler codes3215
Filing names1
Drugs (active)4
Drugs (all time)4
US registrations23
Packages28

Recent events

Shortages, recalls, and registration changes across all filing names.

May 14, 2026
RECALLRecall (Class III): Nicotine Transdermal System Patch, 14 mg, 14 patches per box, Aveva, Distributed by: RUGBY LABORATORIES, Indianapolis, …
Feb 15, 2023
RECALLRecall (Class III): Buprenorphine Transdermal System, CIII 20 mcg/hour, 4 Transdermal Systems One package of 4 disposal units, Rx Only, Man…
Feb 15, 2023
RECALLRecall (Class III): Buprenorphine Transdermal System, CIII 10 mcg/hour, 4 Transdermal Systems One package of 4 disposal units, Rx Only, Man…

Watch this company

Alerts for recalls, exits, and new registrations.

Facility locations, FDA inspections, and parent-company mapping are on the roadmap. Name variants reported to FDA under different spellings are merged into this profile; figures cover the entity across all its filing names.